These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6818603)

  • 1. Influence of age on mianserin pharmacokinetics.
    Altamura AC; Melorio T; Invernizzi G; Gomeni R
    Psychopharmacology (Berl); 1982; 78(4):380-2. PubMed ID: 6818603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mianserin kinetics in depressed patients.
    Hrdina PD; Lapierre YD; McIntosh B; Oyewumi LK
    Clin Pharmacol Ther; 1983 Jun; 33(6):757-62. PubMed ID: 6851406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute bioavailability of mianserin tablets and solution in healthy humans.
    Timmer CJ; Pourbaix S; Desager JP; Sclavons M; Harvengt C
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):315-23. PubMed ID: 3830718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of mianserin in elderly depressed patients.
    Maguire K; McIntyre I; Norman T; Burrows GD
    Psychiatry Res; 1983 Apr; 8(4):281-7. PubMed ID: 6576394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mianserin metabolites.
    Altamura AC; Melorio T
    Br J Clin Pharmacol; 1983 Aug; 16(2):201-3. PubMed ID: 6615696
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics.
    O'Donnell JL; Sharman JR; Begg EJ; Colls BM; Moller PW
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1375-6. PubMed ID: 3933676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in mice.
    Altamura AC; De Novellis F; Mauri MC; Gomeni R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):23-33. PubMed ID: 3602411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-Mianserin binding in calf caudate: possible involvement of serotonin receptors in anti-depressant drug action.
    Whitaker PM; Cross AJ
    Biochem Pharmacol; 1980 Oct; 29(19):2709-12. PubMed ID: 6107087
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline.
    Branconnier RJ; Cole JO; Ghazvinian S; Rosenthal S
    Adv Biochem Psychopharmacol; 1982; 32():195-212. PubMed ID: 7046364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "First-dose" response to mianserin: effects of age.
    Swift CG; Swift MR; Tiplady B
    Psychopharmacology (Berl); 1988; 96(2):273-6. PubMed ID: 3148155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]Mianserin binding to solubilized membranes of frontal cortex.
    Chan B; Madras BK
    Eur J Pharmacol; 1982 Sep; 83(1-2):1-10. PubMed ID: 7128693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification of [3H]mianserin binding sites.
    Chan B; Madras BK
    Eur J Pharmacol; 1983 Mar; 87(4):357-65. PubMed ID: 6852094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic study of mianserin.
    Maguire KP; Norman TR; Burrows GD; Scoggins BA
    Eur J Clin Pharmacol; 1982; 21(6):517-20. PubMed ID: 7075657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mianserin pharmacokinetics and behavior in hyperkinetic children.
    Winsberg BG; Camp-Bruno JA; Vink J; Timmer CJ; Sverd J
    J Clin Psychopharmacol; 1987 Jun; 7(3):143-7. PubMed ID: 3597800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity binding of [3H]mianserin to rat cerebral cortex.
    Dumbrille-Ross A; Tang SW; Seeman P
    Eur J Pharmacol; 1980 Dec; 68(3):395-6. PubMed ID: 6110551
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical study of mianserin, imipramine and placebo in depression: blood level and MHPG correlations.
    Perry GF; Fitzsimmons B; Shapiro L; Irwin P
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):35S-41S. PubMed ID: 341942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of [3H]mianserin and [3H]imipramine to structures of rat hippocampus.
    Brunello N; Chuang DM; Costa E
    Eur J Pharmacol; 1982 Mar; 78(3):383-4. PubMed ID: 7067734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.